Lennar Corp-B
LEN.B
75.75
-0.72
-0.94%
Lennar Corp-B
US · LEN.B
#961 by market cap
Listed 1970
75.75
-0.72
-0.94%
Live - 5344 symbols - heartbeat 103s ago
· 2026-10-08 06:11
Pre-market
75.75
0.00%
After-hours
75.75
0.00%
- Market cap
- 18.02B
- P/E (TTM)i
- 14.35
- P/Bi
- 0.85
- EPSi
- 7.98
- Div yieldi
- 2.64%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on LEN.B?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.66, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.54% YoY
Margins
- Gross margin
- 9.91%
- Operating margin
- 8.05%
- Net margin
- 6.02%
Key ratios & quality
- Altman Z-Scorei
- 3.66
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.57B | 22.26B | 22.49B | 27.13B | 33.67B | 34.23B | 35.44B | 34.19B |
| Gross profit | 2.33B | 2.80B | 3.47B | 5.54B | 7.20B | 5.94B | 5.50B | 3.39B |
| Selling & admin expenses | 343.93M | 321.19M | 333.45M | 398.38M | 414.50M | 501.34M | 648.99M | 636.72M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.99B | 2.48B | 3.14B | 5.14B | 6.79B | 5.44B | 4.85B | 2.75B |
| Pretax profit | 2.26B | 2.43B | 3.12B | 5.82B | 6.01B | 5.20B | 5.18B | 2.81B |
| Tax | 545.17M | 592.17M | 656.24M | 1.36B | 1.37B | 1.24B | 1.22B | 705.56M |
| Net profit | 1.72B | 1.84B | 2.47B | 4.46B | 4.65B | 3.96B | 3.97B | 2.11B |
| Basic EPS | 5 | 6 | 8 | 14 | 16 | 14 | 14 | 8 |
| Diluted EPS | 5.44 | 5.74 | 7.85 | 14.27 | 15.72 | 13.73 | 14.31 | 7.98 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 8.38B | 8.81B | 9.37B | 6.62B | 7.94B | 8.05B |
| Gross profit | 804.43M | 892.60M | 829.05M | 390.70M | 554.96M | 618.54M |
| Selling & admin expenses | 155.85M | 171.40M | 162.09M | 157.64M | 136.15M | 137.88M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 648.58M | 721.20M | 666.96M | 233.06M | 418.82M | 480.65M |
| Pretax profit | 641.88M | 790.70M | 683.04M | 302.45M | 413.19M | 387.08M |
| Tax | 160.06M | 190.89M | 185.09M | 69.09M | 105.06M | 101.59M |
| Net profit | 481.82M | 599.81M | 497.96M | 233.36M | 308.13M | 285.49M |
| Basic EPS | 2 | 2 | 2 | 1 | 1 | 1 |
| Diluted EPS | 1.81 | 2.29 | 1.93 | 0.93 | 1.24 | 1.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 21.30B | 22.24B | 22.66B | 25.14B | 28.39B | 29.35B | 29.31B | 19.39B |
| Cash & ST investments | 1.56B | 1.50B | 2.92B | 2.96B | 4.81B | 6.51B | 4.95B | 3.80B |
| Inventory | 17.37B | 18.09B | 17.18B | 19.17B | 20.10B | 18.90B | 20.31B | 11.84B |
| Total assets | 28.57B | 29.36B | 29.94B | 33.21B | 37.98B | 39.23B | 41.31B | 34.43B |
| Total current liabilities | 1.15B | 1.07B | 1.04B | 1.32B | 1.62B | 1.63B | 1.84B | 1.81B |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 10.12B | 9.57B | 7.42B | 6.38B | 6.20B | 4.98B | 4.19B | 5.87B |
| Total liabilities | 13,883,224,000.00 | 13,325,681,000.00 | 11,835,776,000.00 | 12,211,496,000.00 | 13,743,928,000.00 | 12,532,337,000.00 | 13,291,556,000.00 | 12,289,828,000.00 |
| Total equity | 14.68B | 16.03B | 18.10B | 21.00B | 24.24B | 26.70B | 28.02B | 22.14B |
| Retained earnings | 6.49B | 8.30B | 10.56B | 14.69B | 18.86B | 22.37B | 25.75B | 22.47B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 19.45B | 19.13B | 19.39B | 17.92B | 18.21B | 17.73B |
| Cash & ST investments | 1.45B | 1.70B | 3.80B | 2.39B | 2.13B | 1.47B |
| Inventory | 14.52B | 13.70B | 11.84B | 12.33B | 12.58B | 13.15B |
| Total assets | 34.37B | 34.88B | 34.43B | 33.21B | 33.70B | 33.38B |
| Total current liabilities | 2.13B | 1.52B | 1.81B | 1.74B | 1.78B | 1.80B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 4.21B | 5.39B | 5.87B | 5.26B | 6.01B | 5.88B |
| Total liabilities | 11,642,664,000.00 | 12,126,846,000.00 | 12,289,828,000.00 | 11,178,079,000.00 | 11,935,729,000.00 | 11,681,805,000.00 |
| Total equity | 22.73B | 22.75B | 22.14B | 22.03B | 21.77B | 21.70B |
| Retained earnings | 21.65B | 22.11B | 22.47B | 22.58B | 22.76B | 22.92B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.69B | 1.48B | 4.19B | 2.53B | 3.27B | 5.18B | 2.40B | 216.81M |
| Depreciation & amortization | 91.18M | 92.20M | 94.55M | 85.95M | 87.08M | 110.16M | 115.53M | 134.31M |
| Free cash flow | 1.56B | 1.40B | 4.12B | 2.47B | 3.21B | 5.08B | 2.23B | 28.18M |
| Dividends paid | -49.16M | -51.45M | -195.04M | -309.78M | -438.04M | -430.56M | -548.82M | -520.96M |
| Stock buybacks / issuance | -296.77M | -522.58M | -321.52M | -1.43B | -1.04B | -1.18B | -2.26B | -1.81B |
| Ending cash balance | 1.60B | 1.47B | 2.93B | 2.96B | 4.82B | 6.57B | 4.99B | 3.83B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1.10B | -158.61M | 1.76B | -433.50M | -284.38M | -104.30M |
| Depreciation & amortization | 33.83M | 34.17M | 34.98M | 33.39M | 35.32M | 35.90M |
| Free cash flow | -1.11B | -190.78M | 1.67B | -463.49M | -303.24M | -96.28M |
| Dividends paid | -133.59M | -129.12M | -126.60M | -123.48M | -123.06M | -119.40M |
| Stock buybacks / issuance | -521.42M | -512.42M | -57.00K | -269.71M | -467.09M | -255.90M |
| Ending cash balance | 1.48B | 1.76B | 3.83B | 2.39B | 2.17B | 1.50B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.97 | 12.01 | 14.36 | 22.56 | 20.31 | 15.35 | 14.30 | 8.26 |
| ROA %i | 7.11 | 6.33 | 8.22 | 13.86 | 12.82 | 10.08 | 9.67 | 5.43 |
| ROIC %i | 8.29 | 7.30 | 9.57 | 16.64 | 15.87 | 12.58 | 12.24 | 6.87 |
| 5-year avg ROE %i | 13.84 | 13.43 | 13.27 | 14.93 | 16.84 | 16.92 | 17.38 | 16.16 |
| EBIT margin %i | 9.67 | 11.06 | 13.85 | 18.94 | 20.16 | 15.89 | 13.68 | 8.05 |
| FCF / sales %i | 7.69 | 6.27 | 18.31 | 9.10 | 9.53 | 14.84 | 6.30 | 0.08 |
| Current ratioi | 18.44 | 20.80 | 21.85 | 19.03 | 17.57 | 17.99 | 15.93 | 10.70 |
| Quick ratioi | 3.37 | 3.86 | 5.22 | 4.50 | 5.11 | 6.34 | 4.85 | 4.13 |
| Debt / assetsi | 35.42 | 32.61 | 24.79 | 19.21 | 16.32 | 12.70 | 10.14 | 17.06 |
| LT debt / equityi | 69.38 | 60.03 | 41.24 | 30.64 | 25.72 | 18.75 | 15.03 | 26.75 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 29.49 | 26.68 | 21.15 | 9.66 | 14.79 | 15.03 | 9.32 | 0.51 |
| Net income CAGR (3Y) %i | 28.30 | 26.57 | 44.89 | 37.72 | 35.64 | 16.91 | -3.89 | -23.35 |
| FCF CAGR (3Y) %i | -- | 47.91 | 67.86 | 16.48 | 31.97 | 7.25 | -3.29 | -79.37 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 13.04 | 10.63 | 8.26 | 7.94 | 7.24 | 5.87 |
| ROA %i | 8.83 | 7.12 | 5.43 | 5.19 | 4.70 | 3.80 |
| ROIC %i | 11.25 | 8.98 | 6.87 | 6.62 | 5.88 | 4.68 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.47 | 9.98 | 8.05 | 6.84 | 6.23 | 5.63 |
| FCF / sales %i | 0.79 | -- | 0.08 | -- | 2.19 | 2.54 |
| Current ratioi | 9.15 | 12.57 | 10.70 | 10.31 | 10.20 | 9.87 |
| Quick ratioi | 2.28 | 3.51 | 4.13 | 3.19 | 3.11 | 2.51 |
| Debt / assetsi | 12.24 | 15.45 | 17.06 | 15.83 | 17.84 | 17.62 |
| LT debt / equityi | 18.64 | 23.87 | 26.75 | 24.02 | 27.80 | 27.28 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Homebuilding West is the largest reported line at 32.20% of revenue, across 8 reported segments.
- No single line clears half of revenue; Homebuilding Central is next at 24.20%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Homebuilding West32.20%
Homebuilding Central24.20%
Homebuilding East22.78%
Homebuilding South Central17.21%
Financial services2.81%
Multifamily0.48%
Lennar Other0.27%
Quote time 2026-10-08 06:11:07 · For reference only, not investment advice and not tailored to your situation.